CorMedix Inc.

CRMD · Nasdaq · SIC 2834: Pharmaceutical Preparations
383
SEC Filings

Business Summary

PART I Overview CorMedix Inc. (collectively, with our wholly owned subsidiaries, referred to herein as we, us, our or the Company) is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. Our primary focus has been commercializing DefenCath (taurolidine and heparin), in the U.S., which we launched in 2024 in the hemodialysis setting. The name DefenCath is the U.S. proprietary name approved by the U.S. Food and Dru...

Next Earnings

Q2 FY2026 — expected 2026-09-08

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCRMDdiscussed_in_filing Artificial Intelligence
topic_mentionCRMDdiscussed_in_filing Cybersecurity
topic_mentionCRMDdiscussed_in_filing Trusted Computing
topic_mentionCRMDdiscussed_in_filing Blockchain & Crypto
topic_mentionCRMDdiscussed_in_filing Regulation
topic_mentionCRMDdiscussed_in_filing Healthcare & Bio
topic_mentionCRMDdiscussed_in_filing Platform & Ecosystem
topic_mentionCRMDdiscussed_in_filing Sovereign & Government
topic_mentionCRMDdiscussed_in_filing Artificial Intelligence
topic_mentionCRMDdiscussed_in_filing Cybersecurity
topic_mentionCRMDdiscussed_in_filing Trusted Computing
topic_mentionCRMDdiscussed_in_filing Blockchain & Crypto
topic_mentionCRMDdiscussed_in_filing Regulation
topic_mentionCRMDdiscussed_in_filing Healthcare & Bio
topic_mentionCRMDdiscussed_in_filing Platform & Ecosystem
topic_mentionCRMDdiscussed_in_filing Sovereign & Government
topic_mentionCRMDdiscussed_in_filing Artificial Intelligence
topic_mentionCRMDdiscussed_in_filing Cybersecurity
topic_mentionCRMDdiscussed_in_filing Trusted Computing
topic_mentionCRMDdiscussed_in_filing Blockchain & Crypto

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001213900-26-023889EDGAR66K words
2025-03-252024-12-310001013762-25-001852EDGAR
2024-03-122023-12-310001213900-24-021585EDGAR
2023-03-302022-12-310001213900-23-024310EDGAR
2022-03-292021-12-310001213900-22-015852EDGAR
2021-03-302020-12-310001213900-21-018684EDGAR
2020-03-162019-12-310001213900-20-006521EDGAR
2019-03-142018-12-310001654954-19-002741EDGAR
2018-03-192017-12-310001654954-18-002777EDGAR
2017-03-162016-12-310001654954-17-002094EDGAR

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001213900-25-108777EDGAR42K words
2025-08-072025-06-300001213900-25-072843EDGAR
2025-05-062025-03-310001213900-25-039908EDGAR
2024-10-302024-09-300001213900-24-091961EDGAR
2024-08-142024-06-300001213900-24-068600EDGAR
2024-05-092024-03-310001213900-24-041031EDGAR
2023-11-142023-09-300001213900-23-086981EDGAR
2023-08-082023-06-300001213900-23-064244EDGAR
2023-05-152023-03-310001213900-23-039793EDGAR
2022-11-102022-09-300001213900-22-070834EDGAR
2022-08-112022-06-300001213900-22-046617EDGAR
2022-05-122022-03-310001213900-22-025967EDGAR

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-060001213900-26-024777EDGAR4K words
2026-03-050001213900-26-023881EDGAR
2026-01-080001213900-26-002350EDGAR
2025-11-120001213900-25-108716EDGAR
2025-10-200001213900-25-100156EDGAR
2025-09-020001213900-25-082956EDGAR
2025-08-120001213900-25-075010EDGAR
2025-08-070001213900-25-072814EDGAR
2025-06-300001213900-25-059702EDGAR
2025-06-250001213900-25-057451EDGAR

383 total filings indexed. 351 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001410098
TickerCRMD
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 7b660fa0b0e20551eb7437e5cf4e872d34a5dd5e350a25006e1f4b0cb3cc7e8a
parent: a5860faf0c235c22b9ad87187aaf2160ddf9ee17b481d3f88f107152ffbd2433
content hash: e7b161f38e856d3d5da2670e9e1f27cb419a7c3ee0fbae9b766ce51798bdd348
signed: 2026-04-13T04:44:29.820Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf